|
|
 |
|
News/Event Item
New Vaccine Effective in Preventing TB in African Patients with HIV
Jan. 29, 2010
Investigators from Dartmouth Medical School (DMS) have reported results of a clinical trial showing that a new vaccine against tuberculosis, Mycobacterium vaccae (MV), is effective in preventing tuberculosis in people with HIV infection. The DarDar Health Study, named for Dartmouth and Dar es Salaam, Tanzania, found that MV immunization reduced the rate of definite tuberculosis by 39 percent among 2,000 HIV-infected patients in Tanzania.
The study appears in the January 29, 2010 online issue of the journal AIDS, and it will be published in the March print issue of AIDS.
"Since development of a new vaccine against tuberculosis is a major international health priority, especially for patients with HIV infection, we and our Tanzanian collaborators are very encouraged by the results of the DarDar Study," said Principal Investigator Ford von Reyn, M.D., director of the DarDar International Programs for the Section on Infectious Disease and International Health at DMS.
© 2010 Trustees of Dartmouth College
For full article, visit:
http://www.dartmouth.edu/~news/releases/2010/01/29.html
Related Article:
New Vaccine Promising against TB in HIV Patients
http://www.themedguru.com/20100131/newsfeature/new-vaccine-promising-against-tb-hiv-patients-86132069.html
category: Member Organization News : AIDS News
contributed by Liza Nanni on 1 February 2010
Africa :
recall this item.
|
|
Share
